ATRA Delisted from Nasdaq Global Select Market, $50M MVLS Requirement Missed, 180-Day Compliance Period Until Oct 27 2026, May Seek Capital Market Transfer
Atara Biotherapeutics, Inc · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $10.28
+100% in 7d after detection
Post-detection moves
1h
—
1d
-0.4%
3d
+5.1%
7d
+100%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS